↓ Skip to main content

Dove Medical Press

Article Metrics

Medicinal clays improve the endurance of loaded inspiratory muscles in COPD: a randomized clinical trial of nonpharmacological treatment

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, October 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
2 tweeters
googleplus
1 Google+ user

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
95 Mendeley
Title
Medicinal clays improve the endurance of loaded inspiratory muscles in COPD: a randomized clinical trial of nonpharmacological treatment
Published in
International Journal of Chronic Obstructive Pulmonary Disease, October 2015
DOI 10.2147/copd.s87999
Pubmed ID
Authors

Simonetta Baldi, Gian Domenico Pinna, Claudio Bruschi, Fabrizio Caldara, Elena Dacosto, Paola Crotti, Ermanno Popovich, Ezio Bellinzona, Silvia Montemartini, Claudio Fracchia, Roberto Maestri, Antonella Rezzani

Abstract

Inspiratory resistive breathing (IRB) challenges affect respiratory muscle endurance in healthy individuals, which is considered to be an interleukin 6 (IL-6)-dependent mechanism. Whether nonpharmacological thermal therapies promote the endurance of loaded inspiratory muscles in chronic obstructive pulmonary disease (COPD) is unclear. The objectives of this study were to compare the effects of two thermal interventions on endurance time (ET) and plasma IL-6 concentration following an IRB challenge. This study was a randomized, parallel-group, unblinded clinical trial in a single-center setting. Forty-two patients (aged 42-76 years) suffering from mild to severe COPD participated in this study. Both groups completed 12 sessions of the mud bath therapy (MBT) (n=22) or leisure thermal activity (LTA) (n=19) in a thermal spa center in Italy. Pre- and postintervention spirometry, maximum inspiratory pressure, and plasma mediators were obtained and ET and endurance oxygen expenditure (VO2Endur) were measured following IRB challenge at 40% of maximum inspiratory pressure. There was no difference in ΔIL-6 between the intervention groups. But, IRB challenge increased cytokine IL-6 plasma levels systematically. The effect size was small. A statistically significant treatment by IRB challenge effect existed in ET, which significantly increased in the MBT group (P=0.003). In analysis of covariance treatment by IRB challenge analysis with LnVO2Endur as the dependent variable, ΔIL-6 after intervention predicted LnVO2Endur in the MBT group, but not in the LTA group. Adverse events occurred in two individuals in the MBT group, but they were mainly transient. One patient in the LTA group dropped out. MBT model improves ET upon a moderate IRB challenge, indicating the occurrence of a training effect. The LnVO2Endur/ΔIL-6 suggests a physiologic adaptive mechanism in respiratory muscles of COPD patients allocated to treatment. Both thermal interventions are safe.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
United States 1 1%
Unknown 93 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 22%
Student > Bachelor 15 16%
Researcher 8 8%
Student > Postgraduate 6 6%
Other 3 3%
Other 11 12%
Unknown 31 33%
Readers by discipline Count As %
Nursing and Health Professions 21 22%
Medicine and Dentistry 21 22%
Sports and Recreations 7 7%
Neuroscience 3 3%
Psychology 3 3%
Other 8 8%
Unknown 32 34%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 November 2015.
All research outputs
#2,283,336
of 6,619,724 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#263
of 815 outputs
Outputs of similar age
#73,621
of 209,514 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#32
of 75 outputs
Altmetric has tracked 6,619,724 research outputs across all sources so far. This one has received more attention than most of these and is in the 64th percentile.
So far Altmetric has tracked 815 research outputs from this source. They receive a mean Attention Score of 3.5. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,514 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.